Brind.

Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.

3 reports, 2 independent Updated Aug 29
Gone quiet Reached 2 outlets in its first 24 hours
Reports
3
Developments
2
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.

Who's involved

What this event is mainly about
Bausch Health

How it developed

Newest first. Tap a step to see who reported it.
  1. Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.Sub-event
  2. International revenues grew due to growth in Canada, driven by the segment Salix of Bausch Health.1 source

Keep exploring

The entities involved

  • Bausch Health

    multinational specialty drugs company based in Laval, Quebec, Canada

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • ZacksBausch (BHC) Up 21.4% Since Last Earnings Report: Can It Continue? It has been about a month since the last earnings report for Bausch Health (BHC). Shares have added about 21.4% in that time frame,
  • ZacksBausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat Shares of Bausch Health Companies Inc. (BHC) declined 6.3% after the company reported mixed results for the second quarter of 2025. Adjust
  • GuruFocus.comBausch Health Companies Inc (BHC) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... Revenue: $2,530 million, up 5% on a reported basis and 4% on an organic basis year-over-year. Adjust